Edema Clinical Trials Market Report 2026
Edema Clinical Trials Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Edema Clinical Trials Market Report 2026

Global Outlook – By Phase (Phase I, Phase II, Phase III, Phase IV), By Type (Peripheral Edema, Pulmonary Edema, Cerebral Edema, Nephrotic Syndrome Edema), By Study Design (Interventional, Observational, Expanded Access), By Participant (Pediatrics, Adults, Geriatrics), By End User (Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs), Academic Research Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Edema Clinical Trials Market Overview

• Edema Clinical Trials market size has reached to $1.23 billion in 2025

• Expected to grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: Rising Lifestyle-Related Diseases Driving The Market Growth Due To Unhealthy Lifestyles And Related Health Complications

• Market Trend: Advancements In Sustained-Release Eye Implants For Chronic Edema

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Edema Clinical Trials Market?

Edema clinical trials refer to clinical studies conducted to evaluate the safety, efficacy, and potential treatments for edema, the abnormal accumulation of fluid in the body’s tissues. These trials may investigate drugs, medical devices, or therapeutic interventions aimed at reducing swelling, improving fluid balance, or addressing underlying causes such as heart, kidney, or liver disorders.

The main phase types of edema clinical trials are Phase I, Phase II, Phase III, and Phase IV. Phase I refers to the first stage of clinical trials, focusing on assessing the safety, tolerability, and optimal dosage of a new therapy in a small group of participants. The trials address various types, including peripheral edema, pulmonary edema, cerebral edema, and nephrotic syndrome edema, they are conducted using study designs that include interventional, observational, and expanded access. Participants in these trials span pediatrics, adults, and geriatrics, and the main end users include pharmaceutical companies, research institutions, contract research organizations (CROs), and academic research centers.

Edema Clinical Trials Market Global Report 2026 Market Report bar graph

What Is The Edema Clinical Trials Market Size and Share 2026?

The edema clinical trials market size has grown strongly in recent years. It will grow from $1.23 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular and renal disorders, expansion of clinical research infrastructure, rising pharmaceutical R&D investments, growth in investigator-led trials, improvements in clinical trial management systems.

What Is The Edema Clinical Trials Market Growth Forecast?

The edema clinical trials market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for targeted edema therapies, rising use of decentralized clinical trial models, expansion of precision medicine approaches, growing integration of digital data capture tools, increased regulatory support for innovative trial designs. Major trends in the forecast period include increasing use of AI-assisted patient recruitment, rising adoption of adaptive trial designs, growing focus on biomarker-based endpoints, expansion of multi-center global trials, enhanced emphasis on real-world evidence integration.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Edema Clinical Trials Market Segmentation

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Type: Peripheral Edema, Pulmonary Edema, Cerebral Edema, Nephrotic Syndrome Edema

3) By Study Design: Interventional, Observational, Expanded Access

4) By Participant: Pediatrics, Adults, Geriatrics

5) By End User: Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs), Academic Research Centers

Subsegments:

1) By Phase I: Single Ascending Dose, Multiple Ascending Dose

2) By Phase II: Proof of Concept, Phase IIb Dose Optimization

3) By Phase III: Pivotal Efficacy Trials, Comparative Trials

4) By Phase IV: Post-Marketing Surveillance, Long-Term Safety Studies

What Is The Driver Of The Edema Clinical Trials Market?

The increasing incidence of lifestyle-related diseases is expected to propel the growth of the edema clinical trials market going forward. Lifestyle-related diseases are illnesses that arise from daily behaviors and choices, including sedentary lifestyle, unhealthy eating, and substance use. Lifestyle-related diseases are increasing due to unhealthy dietary habits, as the widespread consumption of processed and high-calorie foods contributes to obesity, diabetes, and cardiovascular problems. Edema clinical trials support lifestyle-related diseases by developing and assessing treatments that address fluid buildup linked to obesity, diabetes, and cardiovascular conditions. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the increasing incidence of lifestyle-related diseases is driving the growth of the edema clinical trials industry.

Key Players In The Global Edema Clinical Trials Market

Major companies operating in the edema clinical trials market are Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, CSL Limited, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Genentech Inc., Ionis Pharmaceuticals Inc., ANI Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Tactile Medical, REGENXBIO Inc., Koya Medical Inc., KalVista Pharmaceuticals Inc., Kodiak Sciences Inc., Pharvaris B.V., Oxurion NV, Outlook Therapeutics Inc., Adverum Biotechnologies Inc., Oculis Holding AG

Global Edema Clinical Trials Market Trends and Insights

Major companies operating in the edema clinical trials market are focusing on developing innovative solutions such as refillable ocular implants to improve treatment efficacy and patient compliance in managing chronic edema-related eye conditions. A refillable ocular implant refers to a medical device implanted in the eye that can continuously deliver medication over an extended period and allows periodic refilling of the drug without needing to remove or replace the implant, ensuring sustained treatment for chronic eye conditions like macular edema. For instance, in February 2025, Roche Holding AG, a Switzerland-based pharmaceutical company, received approval from the FDA for Susvimo as the first and only continuous delivery treatment for diabetic macular edema (DME) and diabetic retinopathy (DR), both major causes of diabetes-related blindness, offering an alternative to frequent eye injections with significantly fewer annual treatments. This innovative approval marks a significant advancement in ophthalmic care, as Susvimo’s implantable delivery system helps improve patient compliance and reduces the treatment burden, potentially enhancing long-term outcomes for individuals living with these chronic eye conditions.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Edema Clinical Trials Market?

In September 2025, Alcon Inc., a Switzerland-based eye care device company, acquired LumiThera Inc. for an undisclosed amount. With this acquisition, Alcon aims to expand access to LumiThera’s Valeda photobiomodulation device for early and intermediate dry AMD, broadening its retinal treatment portfolio into clinic-based, noninvasive therapies to help millions of patients gain vision. LumiThera Inc. is a US-based ophthalmic medical device company that offers edema clinical trials.

Regional Outlook

North America was the largest region in the edema clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Edema Clinical Trials Market?

The edema clinical trials market includes revenues earned by entities by providing services such as patient recruitment and screening, safety and adverse event reporting, and regulatory compliance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Edema Clinical Trials Market Report 2026?

The edema clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the edema clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Edema Clinical Trials Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.34 billion
Revenue Forecast In 2035 $1.85 billion
Growth Rate CAGR of 8.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Phase, Type, Study Design, Participant, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, CSL Limited, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Genentech Inc., Ionis Pharmaceuticals Inc., ANI Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Tactile Medical, REGENXBIO Inc., Koya Medical Inc., KalVista Pharmaceuticals Inc., Kodiak Sciences Inc., Pharvaris B.V., Oxurion NV, Outlook Therapeutics Inc., Adverum Biotechnologies Inc., Oculis Holding AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Edema Clinical Trials Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Edema Clinical Trials Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Edema Clinical Trials Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Edema Clinical Trials Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Ai-Assisted Patient Recruitment

4.2.2 Rising Adoption Of Adaptive Trial Designs

4.2.3 Growing Focus On Biomarker-Based Endpoints

4.2.4 Expansion Of Multi-Center Global Trials

4.2.5 Enhanced Emphasis On Real-World Evidence Integration

5. Edema Clinical Trials Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Research Institutions

5.3 Contract Research Organizations

5.4 Academic Research Centers

5.5 Biotechnology Companies

6. Edema Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Edema Clinical Trials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Edema Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Edema Clinical Trials Market Size, Comparisons And Growth Rate Analysis

7.3. Global Edema Clinical Trials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Edema Clinical Trials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Edema Clinical Trials Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Edema Clinical Trials Market Segmentation

9.1. Global Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phase I, Phase II, Phase III, Phase IV

9.2. Global Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Peripheral Edema, Pulmonary Edema, Cerebral Edema, Nephrotic Syndrome Edema

9.3. Global Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interventional, Observational, Expanded Access

9.4. Global Edema Clinical Trials Market, Segmentation By Participant, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatrics, Adults, Geriatrics

9.5. Global Edema Clinical Trials Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs), Academic Research Centers

9.6. Global Edema Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Ascending Dose, Multiple Ascending Dose

9.7. Global Edema Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proof of Concept, Phase IIb Dose Optimization

9.8. Global Edema Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pivotal Efficacy Trials, Comparative Trials

9.9. Global Edema Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Post-Marketing Surveillance, Long-Term Safety Studies

10. Edema Clinical Trials Market Regional And Country Analysis

10.1. Global Edema Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Edema Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Edema Clinical Trials Market

11.1. Asia-Pacific Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Edema Clinical Trials Market

12.1. China Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Edema Clinical Trials Market

13.1. India Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Edema Clinical Trials Market

14.1. Japan Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Edema Clinical Trials Market

15.1. Australia Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Edema Clinical Trials Market

16.1. Indonesia Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Edema Clinical Trials Market

17.1. South Korea Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Edema Clinical Trials Market

18.1. Taiwan Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Edema Clinical Trials Market

19.1. South East Asia Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Edema Clinical Trials Market

20.1. Western Europe Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Edema Clinical Trials Market

21.1. UK Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Edema Clinical Trials Market

22.1. Germany Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Edema Clinical Trials Market

23.1. France Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Edema Clinical Trials Market

24.1. Italy Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Edema Clinical Trials Market

25.1. Spain Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Edema Clinical Trials Market

26.1. Eastern Europe Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Edema Clinical Trials Market

27.1. Russia Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Edema Clinical Trials Market

28.1. North America Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Edema Clinical Trials Market

29.1. USA Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Edema Clinical Trials Market

30.1. Canada Edema Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Edema Clinical Trials Market

31.1. South America Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Edema Clinical Trials Market

32.1. Brazil Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Edema Clinical Trials Market

33.1. Middle East Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Edema Clinical Trials Market

34.1. Africa Edema Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Edema Clinical Trials Market, Segmentation By Phase, Segmentation By Type, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Edema Clinical Trials Market Regulatory and Investment Landscape

36. Edema Clinical Trials Market Competitive Landscape And Company Profiles

36.1. Edema Clinical Trials Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Edema Clinical Trials Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Edema Clinical Trials Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

37. Edema Clinical Trials Market Other Major And Innovative Companies

CSL Limited, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Genentech Inc., Ionis Pharmaceuticals Inc., ANI Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Tactile Medical, REGENXBIO Inc., Koya Medical Inc., KalVista Pharmaceuticals Inc., Kodiak Sciences Inc., Pharvaris B.V., Oxurion NV, Outlook Therapeutics Inc.

38. Global Edema Clinical Trials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Edema Clinical Trials Market

40. Edema Clinical Trials Market High Potential Countries, Segments and Strategies

40.1 Edema Clinical Trials Market In 2030 - Countries Offering Most New Opportunities

40.2 Edema Clinical Trials Market In 2030 - Segments Offering Most New Opportunities

40.3 Edema Clinical Trials Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Edema Clinical Trials Market, Overview Of Key Products - Product Examples
  • Table 2: Global Edema Clinical Trials Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Edema Clinical Trials Market, Supply Chain Analysis
  • Table 4: Global Edema Clinical Trials Market, Major Raw Material Providers
  • Table 5: Global Edema Clinical Trials Market, Major Resource Providers
  • Table 6: Global Edema Clinical Trials Market, Major Manufacturers (Suppliers)
  • Table 7: Global Edema Clinical Trials Market, Major Distributors And Channel Partners
  • Table 8: Global Edema Clinical Trials Market, Key Technologies & Future Trends
  • Table 9: Global Edema Clinical Trials Market, Major Trends
  • Table 10: Global Edema Clinical Trials Market, Major End Users
  • Table 11: Global Edema Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Edema Clinical Trials Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Edema Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Edema Clinical Trials Market - TAM, US$ Billion, 2025
  • Table 15: Global Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Edema Clinical Trials Market, Segmentation By Participant, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Edema Clinical Trials Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Edema Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Edema Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Edema Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Edema Clinical Trials Market - Company Scoring Matrix
  • Table 100: Roche Holding AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: AbbVie Inc. Financial Performance
  • Table 103: Bayer AG Financial Performance
  • Table 104: Novartis International AG Financial Performance
  • Table 105: Global Edema Clinical Trials Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Edema Clinical Trials Market, Competitive Dashboard
  • Table 107: Global Edema Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030
  • Table 109: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 110: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Study Design, 2025 – 2030

List Of Figures

    Figure 1: Global Edema Clinical Trials Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Edema Clinical Trials Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Edema Clinical Trials Market, Supply Chain Analysis
  • Figure 4: Global Edema Clinical Trials Market, Major Raw Material Providers
  • Figure 5: Global Edema Clinical Trials Market, Major Resource Providers
  • Figure 6: Global Edema Clinical Trials Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Edema Clinical Trials Market, Major Distributors And Channel Partners
  • Figure 8: Global Edema Clinical Trials Market, Key Technologies & Future Trends
  • Figure 9: Global Edema Clinical Trials Market, Major Trends
  • Figure 10: Global Edema Clinical Trials Market, Major End Users
  • Figure 11: Global Edema Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Edema Clinical Trials Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Edema Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Edema Clinical Trials Market - TAM, US$ Billion, 2025
  • Figure 15: Global Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Edema Clinical Trials Market, Segmentation By Participant, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Edema Clinical Trials Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Edema Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Edema Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Edema Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Edema Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Edema Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Edema Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Edema Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Edema Clinical Trials Market - Company Scoring Matrix
  • Figure 100: Roche Holding AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: AbbVie Inc. Financial Performance
  • Figure 103: Bayer AG Financial Performance
  • Figure 104: Novartis International AG Financial Performance
  • Figure 105: Global Edema Clinical Trials Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Edema Clinical Trials Market, Competitive Dashboard
  • Figure 107: Global Edema Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030
  • Figure 109: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 110: Global, Edema Clinical Trials Market Size Gain ($ Billion), Segmentation By Study Design, 2025 – 2030

Frequently Asked Questions

The Edema Clinical Trials market was valued at $1.23 billion in 2025, increased to $1.34 billion in 2026, and is projected to reach $1.85 billion by 2030.

The global Edema Clinical Trials market is expected to grow at a CAGR of 8.5% from 2026 to 2035 to reach $1.85 billion by 2035.

Some Key Players in the Edema Clinical Trials market Include, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, CSL Limited, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Genentech Inc., Ionis Pharmaceuticals Inc., ANI Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Tactile Medical, REGENXBIO Inc., Koya Medical Inc., KalVista Pharmaceuticals Inc., Kodiak Sciences Inc., Pharvaris B.V., Oxurion NV, Outlook Therapeutics Inc., Adverum Biotechnologies Inc., Oculis Holding AG .

Major trend in this market includes: Advancements In Sustained-Release Eye Implants For Chronic Edema. For further insights on this market. request a sample here

North America was the largest region in the edema clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the edema clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts